Power Law company profile

Alder Biopharmaceuticals

Biotech & Life Sciences · Bothell, United States · Founded 2004 · IPO 2014 Unicorn

A biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics

Valuation

$1.95B

Market cap · 2026

Revenue

$1.0M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

7 investors on Alder Biopharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Sevin Rosen Funds

Series B+ 6 investors entered at this stage

TPG Biotech

H.I.G. HealthBridge

Delphi Ventures

HIG Capital

TPG

Novo Ventures

Global footprint

Where Alder Biopharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Bothell HQ

Book a demo for the full country breakdown

Patent intelligence

$129M patent portfolio · 25 active families

Estimated portfolio value

$129M

6.6% of market cap · 2.5× smaller than top peer Genmab ($328M)

25 active patent families

Where Alder Biopharmaceuticals innovates Antiendomysial antibodiesAnti antibodyMolecular biologyAntagonistDisease

Where Alder Biopharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Alder Biopharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Alder Biopharmaceuticals

An AI-synthesized read of the highest-engagement posts about Alder Biopharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alder Biopharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles